A recent study showed that CBX7 recruited p300 acetyltransferase to the DKK1 promoter region, driving DKK1 expression in breast cancer cells and leading to the impairment of Wnt/β-catenin signaling and breast tumorigenesis [15]. Here, CBX7 is linked to breast cancer.